KUSA - TEGNA Investigations examined the lobbying expenditures of 8 major drug companies – with high prescription drug price increases – from 2013-2015.
These companies lobbying more than $100 million in those three years on dozens of issues. This data was provided by The Center for Responsive Politics at OpenSecrets.org.
Can't see the graphic? Click here: http://bit.ly/2fTdsE0
Copyright 2016 KUSA